Fabrice Merien

Dr. Fabrice Merien


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2016 in Frontiers in Public Health
Verified
Journal Article
Open access
FMFabrice Merien
Fabrice Merien
Many reviews of Elie Metchnikoff’s work have been published, all unanimously acknowledging the significant contributions of his cellular theory to the fields of immunology and infectious diseases. In 1883 he published a key paper describing phagocytic cells in frogs. His descriptions were not just about phagocytes involved in host defense, he also described how these specialized cells eliminated degenerating or dying cells of the host. This perspective focuses on key concepts developed by Metchnikoff by presenting relevant excerpts of his 1883 paper and matching these concepts with challenges of modern immunology. A new approach to macrophage polarization is included to introduce some creative thinking about the exciting emerging area of quantum biology.

1 September 2020 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
RGRoffi Grandiosa
Roffi Grandiosa
TYTim Young
Tim Young
TNThao Van Nguyen
Thao Van Nguyen
FMFabrice Merien
Fabrice Merien
AAAndrea Alfaro
Andrea Alfaro

1 February 2018 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
SLStacey Lucas
Stacey Lucas
WCWee Leong Chang
Wee Leong Chang
FMFabrice Merien
Fabrice Merien
To the Editor: The term antinuclear antibodies (ANA) originally referred to autoantibodies directed against nuclear antigens and antigens in the cell cytoplasm or membrane1. The presence of elevated ANA is considered as the hallmark diagnostic test for systemic autoimmune rheumatic diseases (SARD). In most New Zealand (NZ) laboratories, ANA are detected by indirect immunofluorescence test (IIF) on HEp-2. However, fluorescent patterns are sometimes difficult to interpret2,3. Recent advances in autoimmune technologies have emerged for ANA testing, and laboratories in NZ are moving into acquiring the required knowledge and skills. In our laboratory, ANA screening slides are interpreted by a NOVA View automated IIF slide reader (INOVA Diagnostics Inc.), which incorporates a digital analysis image system, pattern recognition algorithms, and preset cutoff values. Problems still exist for the laboratory community to determine whether this system efficiently identifies antigens of clinical significance and whether the different automated systems have an appropriate level of pattern recognition agreement4. The extractable nuclear antigen (ENA) panel is a test performed as … Address correspondence to Dr. F. Merien, Auckland University of Technology, School of Science, 34 St Paul St., Auckland 1142, New Zealand. E-mail: fmerien{at}aut.ac.nz